SYMPOSIA

09.00-10.30 JS-05: Indian Psychiatric Society
Current concept of obsessive compulsive disorder (OCD)
Co-chairs: Manickam Thirunavukarasu, India - Numan Konuk, Türkiye
Current understanding of the concept of obsessive compulsive disorder Manickam Thirunavukarasu, India
Biological theories of obsessive compulsive disorder A. Shyam Sundar, India
Psychopharmacological and somatic interventions in OCD Kandasamy Arun, India
Psycho-social interventions in OCD Manickam Thirunavukarasu, India
10.30 - 11.00 COFFEE BREAK
13.30-15.30 JS-06: Czech NeuroPsychopharmacological Society (CNPS)
From models of schizophrenia to clinical outcome: A psychopharmacological perspective
Co-chairs: Cyril Höschl, Czech Republic - Özcan Uzun, Türkiye
Basic concepts of schizophrenia: Experimental approaches Cyril Höschl, Czech Republic
Prediction validity in animal models of schizophrenia Tomas Palenicek, Czech Republic
The ins and outs of human model of schizophrenia Jiri Horacek, Czech Republic
Safety first, efficacy second? Fear and needs of treatment in the Pavel Mohr, Czech Republic
absence of controlled data
15.30 - 16.00 COFFEE BREAK
NOVEMBER 26, 2011 SATURDAY
16.00-18.00 JS-07: Canadian College of Neuropsychopharmacology
Advances in psychotropic drug development: Promising novel targets and
agents for psychiatric disorders
Co-chairs: Glen Baker, Canada - Mesut Çetin, Türkiye
SCIENTIFIC PROGRAM
HALL A
11.00-12.30 KL-06: Early intervention in anxiety and depression: What we know, Joseph Zohar, Israel
what we don’t know and what we should know?
Chairperson: Oğuz Karamustafalıoğlu, Türkiye
12.30 - 13.30 LUNCH
Novel imidazoline compounds as potential new therapies Alan Leslie Hudson, Canada
for psychiatric disorders
Advances in antipsychotic targets and drug development Serdar Dursun, Canada
Advances in antidepressant targets and drug development Glen Baker, Canada
18.00 - 18.30 COFFEE BREAK